hydroxyindoleacetic acid has been researched along with Tauopathies in 1 studies
(5-hydroxyindol-3-yl)acetic acid : A member of the class of indole-3-acetic acids that is indole-3-acetic acid substituted by a hydroxy group at C-5.
Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kaiserova, M | 1 |
| Chudackova, M | 1 |
| Prikrylova Vranova, H | 1 |
| Mensikova, K | 1 |
| Kastelikova, A | 1 |
| Stejskal, D | 1 |
| Kanovsky, P | 1 |
1 other study available for hydroxyindoleacetic acid and Tauopathies
| Article | Year |
|---|---|
Cerebrospinal Fluid Levels of 5-Hydroxyindoleacetic Acid in Parkinson's Disease and Atypical Parkinsonian Syndromes.
Topics: Diagnosis, Differential; Humans; Hydroxyindoleacetic Acid; Multiple System Atrophy; Parkinson Diseas | 2021 |